Meanwhile, we will clarify whether the PP2A inhibitor LB-100 upregulates the expression of B7-H3 by increasing the phosphorylation of STAT1, which may increase the sensitivity of malignant meningiomas to B7-H3-targeted immunotherapy. This evidence concerns the gene STAT1 and Anaplastic (Malignant) Meningioma.